Global Parkinson’s Disease Treatment Market Size, Status and Forecast 2023-2027

Report ID: 950068 | Published Date: Jan 2025 | No. of Page: 124 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Oral
        1.2.3 Transdermal
        1.2.4 Subcutaneous
        1.2.5 Intestinal Infusion
    1.3 Market by Application
        1.3.1 Global Parkinson’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Parkinson’s Disease Treatment Market Perspective (2016-2027)
    2.2 Parkinson’s Disease Treatment Growth Trends by Regions
        2.2.1 Parkinson’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Parkinson’s Disease Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Parkinson’s Disease Treatment Industry Dynamic
        2.3.1 Parkinson’s Disease Treatment Market Trends
        2.3.2 Parkinson’s Disease Treatment Market Drivers
        2.3.3 Parkinson’s Disease Treatment Market Challenges
        2.3.4 Parkinson’s Disease Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Parkinson’s Disease Treatment Players by Revenue
        3.1.1 Global Top Parkinson’s Disease Treatment Players by Revenue (2016-2021)
        3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Parkinson’s Disease Treatment Revenue
    3.4 Global Parkinson’s Disease Treatment Market Concentration Ratio
        3.4.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2020
    3.5 Parkinson’s Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Parkinson’s Disease Treatment Product Solution and Service
    3.7 Date of Enter into Parkinson’s Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson’s Disease Treatment Breakdown Data by Type
    4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Parkinson’s Disease Treatment Breakdown Data by Application
    5.1 Global Parkinson’s Disease Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Parkinson’s Disease Treatment Market Size (2016-2027)
    6.2 North America Parkinson’s Disease Treatment Market Size by Type
        6.2.1 North America Parkinson’s Disease Treatment Market Size by Type (2016-2021)
        6.2.2 North America Parkinson’s Disease Treatment Market Size by Type (2022-2027)
        6.2.3 North America Parkinson’s Disease Treatment Market Size by Type (2016-2027)
    6.3 North America Parkinson’s Disease Treatment Market Size by Application
        6.3.1 North America Parkinson’s Disease Treatment Market Size by Application (2016-2021)
        6.3.2 North America Parkinson’s Disease Treatment Market Size by Application (2022-2027)
        6.3.3 North America Parkinson’s Disease Treatment Market Size by Application (2016-2027)
    6.4 North America Parkinson’s Disease Treatment Market Size by Country
        6.4.1 North America Parkinson’s Disease Treatment Market Size by Country (2016-2021)
        6.4.2 North America Parkinson’s Disease Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Parkinson’s Disease Treatment Market Size (2016-2027)
    7.2 Europe Parkinson’s Disease Treatment Market Size by Type
        7.2.1 Europe Parkinson’s Disease Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Parkinson’s Disease Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Parkinson’s Disease Treatment Market Size by Type (2016-2027)
    7.3 Europe Parkinson’s Disease Treatment Market Size by Application
        7.3.1 Europe Parkinson’s Disease Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Parkinson’s Disease Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Parkinson’s Disease Treatment Market Size by Application (2016-2027)
    7.4 Europe Parkinson’s Disease Treatment Market Size by Country
        7.4.1 Europe Parkinson’s Disease Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Parkinson’s Disease Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Parkinson’s Disease Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type
        8.2.1 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application
        8.3.1 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region
        8.4.1 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Parkinson’s Disease Treatment Market Size (2016-2027)
    9.2 Latin America Parkinson’s Disease Treatment Market Size by Type
        9.2.1 Latin America Parkinson’s Disease Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Parkinson’s Disease Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Parkinson’s Disease Treatment Market Size by Type (2016-2027)
    9.3 Latin America Parkinson’s Disease Treatment Market Size by Application
        9.3.1 Latin America Parkinson’s Disease Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Parkinson’s Disease Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Parkinson’s Disease Treatment Market Size by Application (2016-2027)
    9.4 Latin America Parkinson’s Disease Treatment Market Size by Country
        9.4.1 Latin America Parkinson’s Disease Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Parkinson’s Disease Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Parkinson’s Disease Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type
        10.2.1 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application
        10.3.1 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country
        10.4.1 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Details
        11.1.2 Teva Business Overview
        11.1.3 Teva Parkinson’s Disease Treatment Introduction
        11.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.1.5 Teva Recent Development
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview
        11.2.3 Roche Parkinson’s Disease Treatment Introduction
        11.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.2.5 Roche Recent Development
    11.3 Prothena
        11.3.1 Prothena Company Details
        11.3.2 Prothena Business Overview
        11.3.3 Prothena Parkinson’s Disease Treatment Introduction
        11.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.3.5 Prothena Recent Development
    11.4 Acorda Therapeutics
        11.4.1 Acorda Therapeutics Company Details
        11.4.2 Acorda Therapeutics Business Overview
        11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Introduction
        11.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.4.5 Acorda Therapeutics Recent Development
    11.5 Voyager Therapeutics
        11.5.1 Voyager Therapeutics Company Details
        11.5.2 Voyager Therapeutics Business Overview
        11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Introduction
        11.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.5.5 Voyager Therapeutics Recent Development
    11.6 Impax Pharmaceuticals
        11.6.1 Impax Pharmaceuticals Company Details
        11.6.2 Impax Pharmaceuticals Business Overview
        11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Introduction
        11.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.6.5 Impax Pharmaceuticals Recent Development
    11.7 UCB
        11.7.1 UCB Company Details
        11.7.2 UCB Business Overview
        11.7.3 UCB Parkinson’s Disease Treatment Introduction
        11.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.7.5 UCB Recent Development
    11.8 AbbVie
        11.8.1 AbbVie Company Details
        11.8.2 AbbVie Business Overview
        11.8.3 AbbVie Parkinson’s Disease Treatment Introduction
        11.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.8.5 AbbVie Recent Development
    11.9 MSD
        11.9.1 MSD Company Details
        11.9.2 MSD Business Overview
        11.9.3 MSD Parkinson’s Disease Treatment Introduction
        11.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.9.5 MSD Recent Development
    11.10 Orion Pharmaceuticals
        11.10.1 Orion Pharmaceuticals Company Details
        11.10.2 Orion Pharmaceuticals Business Overview
        11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Introduction
        11.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.10.5 Orion Pharmaceuticals Recent Development
    11.11 Intec Pharma
        11.11.1 Intec Pharma Company Details
        11.11.2 Intec Pharma Business Overview
        11.11.3 Intec Pharma Parkinson’s Disease Treatment Introduction
        11.11.4 Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.11.5 Intec Pharma Recent Development
    11.12 NeuroDerm
        11.12.1 NeuroDerm Company Details
        11.12.2 NeuroDerm Business Overview
        11.12.3 NeuroDerm Parkinson’s Disease Treatment Introduction
        11.12.4 NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.12.5 NeuroDerm Recent Development
    11.13 Adamas Therapeutics
        11.13.1 Adamas Therapeutics Company Details
        11.13.2 Adamas Therapeutics Business Overview
        11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Introduction
        11.13.4 Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.13.5 Adamas Therapeutics Recent Development
    11.14 Acadia
        11.14.1 Acadia Company Details
        11.14.2 Acadia Business Overview
        11.14.3 Acadia Parkinson’s Disease Treatment Introduction
        11.14.4 Acadia Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.14.5 Acadia Recent Development
    11.15 Sunovion
        11.15.1 Sunovion Company Details
        11.15.2 Sunovion Business Overview
        11.15.3 Sunovion Parkinson’s Disease Treatment Introduction
        11.15.4 Sunovion Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.15.5 Sunovion Recent Development
    11.16 GSK
        11.16.1 GSK Company Details
        11.16.2 GSK Business Overview
        11.16.3 GSK Parkinson’s Disease Treatment Introduction
        11.16.4 GSK Revenue in Parkinson’s Disease Treatment Business (2016-2021)
        11.16.5 GSK Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Oral
    Table 3. Key Players of Transdermal
    Table 4. Key Players of Subcutaneous
    Table 5. Key Players of Intestinal Infusion
    Table 6. Global Parkinson’s Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Parkinson’s Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Parkinson’s Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Parkinson’s Disease Treatment Market Share by Regions (2016-2021)
    Table 10. Global Parkinson’s Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Parkinson’s Disease Treatment Market Share by Regions (2022-2027)
    Table 12. Parkinson’s Disease Treatment Market Trends
    Table 13. Parkinson’s Disease Treatment Market Drivers
    Table 14. Parkinson’s Disease Treatment Market Challenges
    Table 15. Parkinson’s Disease Treatment Market Restraints
    Table 16. Global Parkinson’s Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Parkinson’s Disease Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson’s Disease Treatment as of 2020)
    Table 19. Ranking of Global Top Parkinson’s Disease Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Parkinson’s Disease Treatment Product Solution and Service
    Table 23. Date of Enter into Parkinson’s Disease Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Parkinson’s Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Teva Company Details
    Table 64. Teva Business Overview
    Table 65. Teva Parkinson’s Disease Treatment Product
    Table 66. Teva Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 67. Teva Recent Development
    Table 68. Roche Company Details
    Table 69. Roche Business Overview
    Table 70. Roche Parkinson’s Disease Treatment Product
    Table 71. Roche Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 72. Roche Recent Development
    Table 73. Prothena Company Details
    Table 74. Prothena Business Overview
    Table 75. Prothena Parkinson’s Disease Treatment Product
    Table 76. Prothena Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 77. Prothena Recent Development
    Table 78. Acorda Therapeutics Company Details
    Table 79. Acorda Therapeutics Business Overview
    Table 80. Acorda Therapeutics Parkinson’s Disease Treatment Product
    Table 81. Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 82. Acorda Therapeutics Recent Development
    Table 83. Voyager Therapeutics Company Details
    Table 84. Voyager Therapeutics Business Overview
    Table 85. Voyager Therapeutics Parkinson’s Disease Treatment Product
    Table 86. Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 87. Voyager Therapeutics Recent Development
    Table 88. Impax Pharmaceuticals Company Details
    Table 89. Impax Pharmaceuticals Business Overview
    Table 90. Impax Pharmaceuticals Parkinson’s Disease Treatment Product
    Table 91. Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 92. Impax Pharmaceuticals Recent Development
    Table 93. UCB Company Details
    Table 94. UCB Business Overview
    Table 95. UCB Parkinson’s Disease Treatment Product
    Table 96. UCB Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 97. UCB Recent Development
    Table 98. AbbVie Company Details
    Table 99. AbbVie Business Overview
    Table 100. AbbVie Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 101. AbbVie Recent Development
    Table 102. MSD Company Details
    Table 103. MSD Business Overview
    Table 104. MSD Parkinson’s Disease Treatment Product
    Table 105. MSD Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 106. MSD Recent Development
    Table 107. Orion Pharmaceuticals Company Details
    Table 108. Orion Pharmaceuticals Business Overview
    Table 109. Orion Pharmaceuticals Parkinson’s Disease Treatment Product
    Table 110. Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 111. Orion Pharmaceuticals Recent Development
    Table 112. Intec Pharma Company Details
    Table 113. Intec Pharma Business Overview
    Table 114. Intec Pharma Parkinson’s Disease Treatment Product
    Table 115. Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 116. Intec Pharma Recent Development
    Table 117. NeuroDerm Company Details
    Table 118. NeuroDerm Business Overview
    Table 119. NeuroDerm Parkinson’s Disease Treatment Product
    Table 120. NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 121. NeuroDerm Recent Development
    Table 122. Adamas Therapeutics Company Details
    Table 123. Adamas Therapeutics Business Overview
    Table 124. Adamas Therapeutics Parkinson’s Disease Treatment Product
    Table 125. Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 126. Adamas Therapeutics Recent Development
    Table 127. Acadia Company Details
    Table 128. Acadia Business Overview
    Table 129. Acadia Parkinson’s Disease Treatment Product
    Table 130. Acadia Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 131. Acadia Recent Development
    Table 132. Sunovion Company Details
    Table 133. Sunovion Business Overview
    Table 134. Sunovion Parkinson’s Disease Treatment Product
    Table 135. Sunovion Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 136. Sunovion Recent Development
    Table 137. GSK Company Details
    Table 138. GSK Business Overview
    Table 139. GSK Parkinson’s Disease Treatment Product
    Table 140. GSK Revenue in Parkinson’s Disease Treatment Business (2016-2021) & (US$ Million)
    Table 141. GSK Recent Development
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson’s Disease Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Oral Features
    Figure 3. Transdermal Features
    Figure 4. Subcutaneous Features
    Figure 5. Intestinal Infusion Features
    Figure 6. Global Parkinson’s Disease Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Pharmacy Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Online Pharmacy Case Studies
    Figure 10. Parkinson’s Disease Treatment Report Years Considered
    Figure 11. Global Parkinson’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Parkinson’s Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Parkinson’s Disease Treatment Market Share by Regions: 2020 VS 2027
    Figure 14. Global Parkinson’s Disease Treatment Market Share by Regions (2022-2027)
    Figure 15. Global Parkinson’s Disease Treatment Market Share by Players in 2020
    Figure 16. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson’s Disease Treatment as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Parkinson’s Disease Treatment Revenue in 2020
    Figure 18. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2016-2021)
    Figure 19. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2022-2027)
    Figure 20. North America Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Parkinson’s Disease Treatment Market Share by Type (2016-2027)
    Figure 22. North America Parkinson’s Disease Treatment Market Share by Application (2016-2027)
    Figure 23. North America Parkinson’s Disease Treatment Market Share by Country (2016-2027)
    Figure 24. United States Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Parkinson’s Disease Treatment Market Share by Type (2016-2027)
    Figure 28. Europe Parkinson’s Disease Treatment Market Share by Application (2016-2027)
    Figure 29. Europe Parkinson’s Disease Treatment Market Share by Country (2016-2027)
    Figure 30. Germany Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Parkinson’s Disease Treatment Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Parkinson’s Disease Treatment Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Parkinson’s Disease Treatment Market Share by Region (2016-2027)
    Figure 40. China Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Parkinson’s Disease Treatment Market Share by Type (2016-2027)
    Figure 48. Latin America Parkinson’s Disease Treatment Market Share by Application (2016-2027)
    Figure 49. Latin America Parkinson’s Disease Treatment Market Share by Country (2016-2027)
    Figure 50. Mexico Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Parkinson’s Disease Treatment Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Parkinson’s Disease Treatment Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Parkinson’s Disease Treatment Market Share by Country (2016-2027)
    Figure 56. Turkey Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Parkinson’s Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Teva Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 60. Roche Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 61. Prothena Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 62. Acorda Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 63. Voyager Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 64. Impax Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 65. UCB Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 66. AbbVie Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 67. MSD Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 68. Orion Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 69. Intec Pharma Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 70. NeuroDerm Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 71. Adamas Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 72. Acadia Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 73. Sunovion Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 74. GSK Revenue Growth Rate in Parkinson’s Disease Treatment Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Roche
Prothena
Acorda Therapeutics
Voyager Therapeutics
Impax Pharmaceuticals
UCB
AbbVie
MSD
Orion Pharmaceuticals
Intec Pharma
NeuroDerm
Adamas Therapeutics
Acadia
Sunovion
GSK
Frequently Asked Questions
Parkinson’s Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Parkinson’s Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Parkinson’s Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

At-Need Death Care

Death care includes companies who provide death-related goods and services such as funerals, buri ... Read More